(Q37502469)

20 August 2017

1 reference

title

Vaccine adherence in adolescents (English)

1 reference

20 August 2017

1 reference

Corinne Lehmann

1

1 reference

20 August 2017

Paul A S Benson

series ordinal

2

1 reference

20 August 2017

publication date

29 May 2009

1 reference

20 August 2017

1 reference

20 August 2017

volume

48

1 reference

20 August 2017

issue

8

1 reference

20 August 2017

page(s)

801-811

1 reference

New, and some not-so-new, vaccines for adolescents and diseases they prevent

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

EPIDEMIOLOGY OF A SMALL PERTUSSIS OUTBREAK IN KENT COUNTY, MICHIGAN

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

Declining pertussis incidence in Sweden following the introduction of acellular pertussis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

Duration of immunity against pertussis after natural infection or vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

Prevalence of HPV infection among females in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

Screening HIV-infected individuals for anal cancer precursor lesions: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

The causal relation between human papillomavirus and cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

Atypical squamous cells of undetermined significance: human papillomavirus testing in adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

Natural history of cervicovaginal papillomavirus infection in young women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

Randomized controlled trial of an adjuvanted human papillomavirus (HPV) type 6 L2E7 vaccine: infection of external anogenital warts with multiple HPV types and failure of therapeutic vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

Economic Evaluation of the 7-Vaccine Routine Childhood Immunization Schedule in the United States, 2001

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

Invasive meningococcal disease epidemiology and control measures: a framework for evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

Evaluating human papillomavirus vaccination programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

Immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in healthy boys aged 10-18 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

Parental acceptance of the human papillomavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

Influenza vaccination rates and motivators among healthcare worker groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

The influence of staff and resident immunization rates on influenza-like illness outbreaks in nursing homes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

A national survey of pediatrician knowledge and attitudes regarding human papillomavirus vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

Pediatricians' intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

Provider-staff discrepancies in reported immunization knowledge and practices

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

Mandates for adolescent immunizations: recommendations from the National Vaccine Advisory Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

Patient reminder and recall systems to improve immunization rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

How do you improve compliance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

The promise and challenge of adolescent immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

National health care visit patterns of adolescents: implications for delivery of new adolescent vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

Nonmedical Exemptions to School Immunization Requirements

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

Pertussis Immunization of Adolescents in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0009922809336360

21 January 2018

Identifiers

DOI

10.1177/0009922809336360

1 reference

release_b5m2cwxpjrc2xgjzohzxuqefpu

20 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/b5m2cwxpjrc2xgjzohzxuqefpu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference